| 3.14 Data as of May 22 |  -0.01 / -0.32%Today’s Change | 2.11 Today|||52-Week Range 3.76 | +7.53% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP $259.7M |
Immunomedics, Inc. 300 The American Road Morris Plains New Jersey 07950 |
| Individual stakeholders | 6.34% |
| Mutual fund holders | 24.77% |
| Other institutional | 15.10% |
| David M. Goldenberg, MD | Chairman, Chief Scientific & Medical Officer |
| Cynthia L. Sullivan, MBA | President, Chief Executive Officer & Director |
| Gerard G. Gorman, MBA | Chief Financial Officer & Senior Vice President |
| William A. Wegener, MD, PhD | Senior Vice President-Clinical Research |
| Hans J. Hansen, PhD | Vice President-Emeritus |
.
